Bilim Pharmaceuticals global vision is to continue being among the biggest exporters and to become a net exporter by 2023. As the International Markets Department, we carry out our commercial activities in external markets in line with our growth strategy and company vision. 

Bilim Pharmaceuticals started international expansion in 1998. Since the beginning of our export journey we have been using our expertise in international sales and promotion activities. In order to strengthen its presence in international markets, Bilim Pharmaceuticals has set up representative offices in Moldova and Albania where over 30 people are currently employed. 

Bilim Pharmaceuticals quality has been consistently approved in the international arena by various authorities and major multinational companies. 88 products from our portfolio are being safely prescribed in over 70 different countries around the world. 

With the support of our export dedicated Regulatory Affairs Department, we hold over 1.200 marketing authorizations in foreign countries. Our aim is to steadily add new generic products to our export portfolio.

Bilim Pharmaceuticals provides a wide range of products for export partners. Our goal is to reach sustainable growth with  our partners with a win-to-win approach. Knowing the importance of flexibility, we rapidly adapt to changing customer demands and market dynamics to gain a competitive edge.

At Bilim Pharmaceuticals, we provide the following global partnership opportunities:

Our fundamental capabilities

As a pioneering manufacturer in Turkey, we keep track on recent technological developments and continually renew our production machinery and equipment. Our EU-GMP approved Bilim Gebze plant’s -non-penicillin and non-cephalexin products- capacity is 250 million packs per year. Our Çerkezköy Beta Lactam plant has been also been approved by EU authorities and has a capacity of 44 million packs per year.